People with lung conditions such as asthma, COPD, and emphysema need to be particularly careful in the cold because breathing in cold air can constrict airway muscles making it harder to breathe, so ...

Asthma is a complicated condition, one that has multiple causes, varying degrees of severity, and no cure. Therefore, treating asthma is a matter of managing it to ward off symptoms and prevent ...

"and to follow an asthma action plan developed with your doctor so you know when to use both preventative daily-controller medications and as-needed rescue medications," advises Conrad.

William B. Feldman, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily metered dose ...

FDA-approved rescue inhaler for asthma in patients aged 18 and older. Combining albuterol, a bronchodilator, and budesonide, an anti-inflammatory corticosteroid, it offers dual-action relief from ...

eMEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal fCINTESIS@RISE–Health Research Network, Faculty of ...

aCentre for Healthcare Transformation, Queensland University of Technology and Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, QLD, Australia ...

Systemic corticosteroids (CS) should be considered as first-line treatment for acute asthma exacerbations ... a proposal for the use of inhaled CS as a rescue medication in the emergency ...

More information: William B Feldman et al, Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study, BMJ (2024).

Clinical evidence shows that inhaled CS present early benefits (within 1-2 h) for the treatment of children and adults with acute asthma. Patients (children and adults) who received inhaled CS ...

Most people with asthma can be effectively managed with an inhaled corticosteroid (ICS), alone or in combination with a long-acting β2-agonist (LABA). However, a significant number of patients with ...